Last edition
News about Global Pharma
Solvias to Build Biologics and Cell and Gene Therapy Testing Center
Solvias has been planning to expand its global network of laboratory testing centers with a new biotech site in Research Triangle Park, N.C.
Global Pharma | 07/05/2024 | By Aishwarya | 632
This agreement is the second such agreement in as many months shows TCBP's commitment to its M&A strategy aimed at expanding its therapeutic platform.
Global Pharma | 06/05/2024 | By Manvi | 374
Inspira Technologies Commences Production of INSPIRA ART100 Medical Device
This manufacturing partner has initiated the production and assembly process for the first batch of INSPIRA ART100 devices.
Global Pharma | 06/05/2024 | By Abha | 881
This approval provides an alternative administration option for individuals experiencing dysphagia or difficulty swallowing.
Global Pharma | 06/05/2024 | By Abha | 420
RaySearch Join Forces with C-RAD to Enhance Quality of Radiation Therapy
RaySearch Laboratories has signed a collaboration deal with C-RAD, aimed at developing innovative solutions and products to enhance the quality of radiation therapy.
Global Pharma | 06/05/2024 | By Aishwarya | 839
Novartis to Acquire Mariana Oncology to Expand RLT Pipeline
Novartis has decided to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts focused on developing novel radioligand therapies (RLTs) to treat cancers with high unmet patient needs.
Global Pharma | 04/05/2024 | By Aishwarya | 831
SonoVascular Partners with Lantheus for Innovative Treatment of Venous Thromboembolism
The collaboration aims to utilize Lantheus' microbubbles in conjunction with SonoVascular's innovative SonoThrombectomy System to treat deep vein thrombosis (DVT) and pulmonary embolism (PE).
Global Pharma | 04/05/2024 | By Abha | 610
Sentynl Therapeutics Completes Acquisition of Eiger BioPharmaceuticals' Zokinvy Program
Zokinvy is the first and only treatment approved by the US Food and Drug Administration (FDA) for Hutchinson-Gilford progeria syndrome (HGPS) and processing-deficient progeroid laminopathies (PDPL).
Global Pharma | 04/05/2024 | By Abha | 1087
MedRes Opens Medical Device Technology Center in Carlsbad, CA
The Carlsbad site is equipped to accelerate customer projects in the fields of cardiovascular intervention and minimally invasive surgery.
Global Pharma | 03/05/2024 | By Manvi | 460
Anaut Announces Japanese Regulatory Approval of AI-Powered Surgical Visualization Tool, Eureka
Anaut Inc., a pioneering developer in surgical support software led by CEO Dr. Nao Kobayashi, announced regulatory approval of its groundbreaking medical device, 'Eureka α'.
Global Pharma | 03/05/2024 | By Manvi | 760
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy